Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b trial of MenABCWY in healthy infants
2020-000948-60Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of Meningococcal ABCYW vaccine in meningococcal disease (2 arms), sponsored by Pfizer. Primary endpoint: Immunogenicity objectives. Started Sep 2020; status: terminated.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2020-000948-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000948-60.